Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse 21:00:13 12/06/2024 BST 5-day change 1st Jan Change
130.2 USD -1.24% Intraday chart for Merck & Co., Inc. +0.58% +19.43%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Merck looks for next-generation opportunities in cardiometabolic drugs RE
Merck & Co., Inc. to Seek Acquisitions CI
Transcript : Merck & Co., Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-11-2024 10:00 AM
HSBC Adjusts Price Target on Merck & Co. to $130 From $118, Keeps Hold Rating MT
Transcript : Merck & Co., Inc. Presents at 2024 American Society of Clinical Oncology Annual Meeting, Jun-03-2024 06:00 PM
Merck: promising results in melanoma treatment CF
Merck, Moderna Drug Combo Shows Improved Survival in Skin Cancer Trial DJ
Moderna, Merck Say 3-Year Data for Melanoma Combination Therapy Show Continued Improvement in Recurrence-Free Survival MT
Moderna & Merck Announces 3-Year Data for mRNA-4157 in Combination with KEYTRUDA (Pembrolizumab) CI
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up RE
Immutep, Merck Collaborate on Trial for Lung Cancer Therapy MT
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival RE
Sector Update: Health Care MT
Declaration of Voting Results by Merck & Co CI
Declaration of Voting Results by Merck & Co CI
Declaration of Voting Results by Merck & Co CI
Declaration of Voting Results by Merck & Co CI
US Equities Markets Close Lower Thursday After Q1 Economic Growth Found to be Slower Than Projected MT
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar MT
Summit Therapeutics Shares Triple After Drug Candidate Data DJ
Summit Therapeutics cancer therapy succeeds in late-stage China study RE
Merck Signs MoU with KAIST to Advance Scientific Collaboration CI
Sector Update: Health Care Stocks Fall Late Afternoon MT
Sector Update: Health Care Stocks Retreat Wednesday Afternoon MT
Sector Update: Health Care MT
Chart Merck & Co., Inc.
More charts
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.2 USD
Average target price
142.7 USD
Spread / Average Target
+9.59%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck & Co., Inc.
  5. Sector Update: Health Care Stocks Fall Late Afternoon
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW